...
alzn-img

Alzamend Neuro Inc, Common Stock

ALZN

NAQ

$1.22

+$0.03

(2.52%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$6.47M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
255.09K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-0.04
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.06 L
$12.9 H
$1.22

About Alzamend Neuro Inc, Common Stock

Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002 stage, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. The company has partnership agreement with Massachusetts General Hospital for the Phase II clinical trial of AL001. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameALZNSectorS&P500
1-Week Return-2.4%-3.72%-0.05%
1-Month Return-9.63%-1.85%2.75%
3-Month Return-32.97%-11.4%7.4%
6-Month Return-69.5%-4.41%10.47%
1-Year Return-87.8%4.13%27.57%
3-Year Return-99.68%0.3%29.56%
5-Year Return-99.94%36.62%89.3%

Financials

Apr '20Apr '21Apr '22Apr '23Apr '245YR TREND
Total Revenue-----[{"date":"2020-04-30","value":"-","profit":true},{"date":"2021-04-30","value":"-","profit":true},{"date":"2022-04-30","value":"-","profit":true},{"date":"2023-04-30","value":"-","profit":true},{"date":"2024-04-30","value":"-","profit":true}]
Cost of Revenue---23.07K50.74K[{"date":"2020-04-30","value":"-","profit":true},{"date":"2021-04-30","value":"-","profit":true},{"date":"2022-04-30","value":"-","profit":true},{"date":"2023-04-30","value":45.46,"profit":true},{"date":"2024-04-30","value":100,"profit":true}]
Gross Profit---(23.07K)(50.74K)[{"date":"2020-04-30","value":"-","profit":true},{"date":"2021-04-30","value":"-","profit":true},{"date":"2022-04-30","value":"-","profit":true},{"date":"2023-04-30","value":-2306600,"profit":false},{"date":"2024-04-30","value":-5074000,"profit":false}]
Gross Margin-----[{"date":"2020-04-30","value":"-","profit":true},{"date":"2021-04-30","value":"-","profit":true},{"date":"2022-04-30","value":"-","profit":true},{"date":"2023-04-30","value":"-","profit":true},{"date":"2024-04-30","value":"-","profit":true}]
Operating Expenses4.42M4.95M12.32M14.87M9.94M[{"date":"2020-04-30","value":29.75,"profit":true},{"date":"2021-04-30","value":33.3,"profit":true},{"date":"2022-04-30","value":82.85,"profit":true},{"date":"2023-04-30","value":100,"profit":true},{"date":"2024-04-30","value":66.83,"profit":true}]
Operating Income(4.42M)(4.95M)(12.32M)(14.87M)(9.94M)[{"date":"2020-04-30","value":-442416100,"profit":false},{"date":"2021-04-30","value":-495188800,"profit":false},{"date":"2022-04-30","value":-1231953500,"profit":false},{"date":"2023-04-30","value":-1487046600,"profit":false},{"date":"2024-04-30","value":-993764500,"profit":false}]
Total Non-Operating Income/Expense27.85K(251.78K)(89.05K)(15.40K)(20.20K)[{"date":"2020-04-30","value":100,"profit":true},{"date":"2021-04-30","value":-904.04,"profit":false},{"date":"2022-04-30","value":-319.74,"profit":false},{"date":"2023-04-30","value":-55.3,"profit":false},{"date":"2024-04-30","value":-72.54,"profit":false}]
Pre-Tax Income(4.41M)(5.05M)(12.36M)(14.88M)(9.95M)[{"date":"2020-04-30","value":-441023600,"profit":false},{"date":"2021-04-30","value":-504656700,"profit":false},{"date":"2022-04-30","value":-1236205900,"profit":false},{"date":"2023-04-30","value":-1487816700,"profit":false},{"date":"2024-04-30","value":-994774600,"profit":false}]
Income Taxes(13.93K)157.10K42.52K(144.83K)-[{"date":"2020-04-30","value":-8.86,"profit":false},{"date":"2021-04-30","value":100,"profit":true},{"date":"2022-04-30","value":27.07,"profit":true},{"date":"2023-04-30","value":-92.19,"profit":false},{"date":"2024-04-30","value":"-","profit":true}]
Income After Taxes(4.40M)(5.20M)(12.40M)(14.73M)-[{"date":"2020-04-30","value":-439631100,"profit":false},{"date":"2021-04-30","value":-520366400,"profit":false},{"date":"2022-04-30","value":-1240458300,"profit":false},{"date":"2023-04-30","value":-1473333800,"profit":false},{"date":"2024-04-30","value":"-","profit":true}]
Income From Continuous Operations(4.41M)(5.05M)(12.36M)(14.88M)(9.95M)[{"date":"2020-04-30","value":-441023600,"profit":false},{"date":"2021-04-30","value":-504656700,"profit":false},{"date":"2022-04-30","value":-1236205900,"profit":false},{"date":"2023-04-30","value":-1487816700,"profit":false},{"date":"2024-04-30","value":-994774700,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-04-30","value":"-","profit":true},{"date":"2021-04-30","value":"-","profit":true},{"date":"2022-04-30","value":"-","profit":true},{"date":"2023-04-30","value":"-","profit":true},{"date":"2024-04-30","value":"-","profit":true}]
Net Income(4.40M)(5.20M)(12.40M)(14.88M)(9.95M)[{"date":"2020-04-30","value":-439631100,"profit":false},{"date":"2021-04-30","value":-520366400,"profit":false},{"date":"2022-04-30","value":-1240458300,"profit":false},{"date":"2023-04-30","value":-1487816700,"profit":false},{"date":"2024-04-30","value":-994774600,"profit":false}]
EPS (Diluted)(0.07)(0.06)(0.14)(0.15)(14.21)[{"date":"2020-04-30","value":-6.68,"profit":false},{"date":"2021-04-30","value":-5.7,"profit":false},{"date":"2022-04-30","value":-14,"profit":false},{"date":"2023-04-30","value":-15,"profit":false},{"date":"2024-04-30","value":-1421,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

ALZN
Cash Ratio 3.26
Current Ratio 3.80

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ALZN
ROA (LTM) -214.47%
ROE (LTM) -4408.31%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ALZN
Debt Ratio Lower is generally better. Negative is bad. 0.25
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.75

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ALZN
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 1.72
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Alzamend Neuro Inc share price today?

Alzamend Neuro Inc (ALZN) share price today is $1.22

Can Indians buy Alzamend Neuro Inc shares?

Yes, Indians can buy shares of Alzamend Neuro Inc (ALZN) on Vested. To buy Alzamend Neuro Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ALZN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Alzamend Neuro Inc be purchased?

Yes, you can purchase fractional shares of Alzamend Neuro Inc (ALZN) via the Vested app. You can start investing in Alzamend Neuro Inc (ALZN) with a minimum investment of $1.

How to invest in Alzamend Neuro Inc shares from India?

You can invest in shares of Alzamend Neuro Inc (ALZN) via Vested in three simple steps:

  • Click on Sign Up or Invest in ALZN stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Alzamend Neuro Inc shares
What is Alzamend Neuro Inc 52-week high and low stock price?

The 52-week high price of Alzamend Neuro Inc (ALZN) is $12.9. The 52-week low price of Alzamend Neuro Inc (ALZN) is $1.06.

What is Alzamend Neuro Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Alzamend Neuro Inc (ALZN) is

What is Alzamend Neuro Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Alzamend Neuro Inc (ALZN) is 1.72

What is Alzamend Neuro Inc dividend yield?

The dividend yield of Alzamend Neuro Inc (ALZN) is 0.00%

What is the Market Cap of Alzamend Neuro Inc?

The market capitalization of Alzamend Neuro Inc (ALZN) is $6.47M

What is Alzamend Neuro Inc’s stock symbol?

The stock symbol (or ticker) of Alzamend Neuro Inc is ALZN

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top